| Literature DB >> 26293656 |
Sascha Weiss1, Franka Messner2, Marcus Huth3, Annemarie Weissenbacher4, Christian Denecke5, Felix Aigner6, Andreas Brandl7, Tomasz Dziodzio8, Robert Sucher9, Claudia Boesmueller10, Robert Oellinger11, Stefan Schneeberger12, Dietmar Oefner13, Johann Pratschke14, Matthias Biebl15.
Abstract
BACKGROUND: Depending on the extent of surgery, coagulation status and the number of anastomoses, drains are routinely used during liver transplantation. The aim of this study was to compare different drain types with regard to abdominal complication rates.Entities:
Mesh:
Year: 2015 PMID: 26293656 PMCID: PMC4546128 DOI: 10.1186/s40001-015-0163-z
Source DB: PubMed Journal: Eur J Med Res ISSN: 0949-2321 Impact factor: 2.175
Preoperative donor and recipient features
| Parameters | Group 1 (open drainage) | Group 2 (closed drainage) |
|
|---|---|---|---|
| Number of patients | 56 | 200 | |
| Donor age (years) | 46.5 (24–74) | 49.0 (15–76) | 0.7 (ns) |
| Donor gender (m:f) | 29:27 | 96:104 | 0.4 (ns) |
| Donor CMV-positive | 34 (61 %) | 110 (55 %) | 0.2 (ns) |
| Donor ICU stay (days) | 6 (1–16) | 5 (1–14) | 0.7 (ns) |
| Donor steatosis hepatis | |||
| No | 42 (75 %) | 161 (80 %) | 0.8 (ns) |
| Moderate | 11 (20 %) | 35 (17.5 %) | 0.9 (ns) |
| Severe | 3 (5 %) | 4 (2 %) | 0.8 (ns) |
| Recipient age (years) | 51.4 (12–68) | 52.6 (16–67) | 0.3 (ns) |
| Recipient gender (m:f) | 44:12 | 153:47 | 0.9 (ns) |
| Recipient CMV-positive | 37 (66 %) | 141 (70 %) | 0.3 (ns) |
| CMV (donor+/recip.−) | 12 (21 %) | 38 (19 %) | 0.8 (ns) |
| MELD score | 17.0 (8–39) | 16 (7–40) | 0.3 (ns) |
| Body Mass Index | 25.9 (17.4–35.4) | 26.6 (18.5–36.2) | 0.9 (ns) |
| Underlying disease | |||
| Hepatitis B | 5 (9 %) | 13 (7 %) | 0.4 (ns) |
| Hepatitis C | 13 (23 %) | 47 (24 %) | 0.6 (ns) |
| Cryptogenic | 2 (4 %) | 12 (6 %) | 0.4 (ns) |
| Primary biliary cirrhosis | 1 (2 %) | 9 (4.5 %) | 0.3 (ns) |
| Biliary atresia | 0 | 1 (0.5 %) | 0.8 (ns) |
| Sclerosing cholangitis | 1 (2 %) | 5 (2.5 %) | 0.6 (ns) |
| Autoimmune hepatitis | 1 (2 %) | 4 (2 %) | 0.7 (ns) |
| Metabolic | 0 | 11 (5.5 %) | 0.1 (ns) |
| Acute liver failure | 4 (7 %) | 14 (7 %) | 0.6 (ns) |
| Chronic alcoholic | 29 (52 %) | 84 (42 %) | 0.5 (ns) |
| Presence of HCCa | 24 (43 %) | 69 (34.5 %) | 0.1 (ns) |
| Child-Pugh score | |||
| Child A | 10 (18 %) | 42 (21 %) | 0.9 (ns) |
| Child B | 32 (57 %) | 110 (55 %) | 0.9 (ns) |
| Child C | 14 (25 %) | 48 (24 %) | 0.8 (ns) |
| Previous abdominal surgery | 24 (43 %) | 85 (42.5 %) | 0.5 (ns) |
| Preoperative portal vein thrombosis | 2 (4 %) | 10 (5 %) | 0.5 (ns) |
| Retransplantation | 3 (5 %) | 15 (7.5 %) | 0.4 (ns) |
Values are expressed as median (range)
Group 1 open-circuit drainage (Easy Flow Drain), Group 2 closed-circuit drainage (Robinson Drainage System)
aHepatocellular carcinoma
Recipient features peri- and intraoperatively and immunosuppression
| Parameters | Group 1 (open drainage) | Group 2 (closed drainage) |
|
|---|---|---|---|
| Number of patients | 56 | 200 | |
| Liver transplantation technique | |||
| Piggyback technique | 2 (4 %) | 6 (3 %) | 0.5 (ns) |
| Retrohepatic caval resection | 54 (96 %) | 194 (97 %) | 0.5 (ns) |
| Bile duct anastomosis | |||
| End-to-end | 24 (43 %) | 97 (49 %) | 0.6 (ns) |
| Side-to-side | 32 (57 %) | 103 (51 %) | 0.5 (ns) |
| T tube insertion (yes:no) | 8:48 | 16:184 | 0.1 (ns) |
| Drain removal (postoperative day) | 6 (4–13) | 5 (5–11) | 0.7 (ns) |
| Immunosuppression | |||
| Tacrolimus and MMF | 38 (68 %) | 140 (70 %) | 0.8 (ns) |
| Cyclosporin and MMF | 11 (20 %) | 52 (26 %) | 0.8 (ns) |
| Simulect | 53 (95 %) | 185 (92 %) | 0.9 (ns) |
| Cold ischemia time (min) | 512 (212–954) | 528 (229–1098) | 0.7 (ns) |
| Operative time (min) | 362 (238–712) | 358 (360–643) | 0.9 (ns) |
| Intraoperative blood transfusion (units) | 4 (0–31) | 3.5 (0–23) | 0.3 (ns) |
| Intraoperative platelet transfusion (units) | 2 (0–6) | 2.5 (0–7) | 0.4 (ns) |
| Intraoperative plasma transfusion (units) | 6 (2–29) | 7 (1–31) | 0.6 (ns) |
Values are expressed as median (range)
Group 1 open-circuit drainage (Easy Flow Drain), Group 2 closed-circuit drainage (Robinson Drainage System)
Outcome and surgical morbidity following liver transplantation
| Parameters | Group 1, | Group 2, |
|
|
|---|---|---|---|---|
| Primary non-function | 1 (2 %) | 3 (1.5 %) | 0.6 (ns) | – |
| Postoperative ICU stay (days) | 5 (2–57) | 4 (1–59) | 0.4 (ns) | – |
| Postoperative hospital stay (days) | 23 (11–108) | 21 (13–98) | 0.3 (ns) | – |
| Postoperative severe acute renal failure with dialysis | 13 (23 %) | 39 (19.5 %) | 0.7 (ns) | – |
| Acute rejection | 12 (21 %) | 21 (10.5 %) |
| 0.06 (NS) |
| Reoperation | 31 (55 %) | 82 (41 %) |
| 0.07 (NS) |
| Bleeding | 15 (27 %) | 34 (17 %) | 0.07 (ns) | – |
| Hematoma | 21 (38 %) | 39 (20 %) |
|
|
| Ascites | 0 | 2 (1 %) | 0.6 (ns) | – |
| Wound healing complication | 8 (14 %) | 18 (9 %) | 0.2 (ns) | – |
| Neurological complication | 4 (7 %) | 17 (9 %) | 0.5 (ns) | – |
| Hepatic artery dissection | 1 (2 %) | 1 (0.5 %) | 0.4 (ns) | – |
| Hepatic artery thrombosis | 1 (2 %) | 2 (1 %) | 0.5 (ns) | – |
| Portal vein thrombosis | 0 | 2 (1 %) | 0.6 (ns) | – |
| Bile duct leak | 2 (3.6 %) | 12 (6 %) | 0.4 (ns) | – |
| Bile duct ischemia | 0 | 1 (0.5 %) | 0.6 (ns) | – |
| Bile duct stenosis | 3 (5.4 %) | 6 (3 %) | 0.4 (ns) | – |
| Cholestasis | 5 (9 %) | 8 (4 %) | 0.1 (ns) | – |
Values are expressed as median (range)
Italic values indicate statistical significance of p value (p > 0.05)
Group 1 open-circuit drainage (Easy Flow Drain), Group 2 closed-circuit drainage (Robinson Drainage System)
Multivariate regression analysis of infection following liver transplantation after exclusion of non-significant parameters in univariate analysis
| Parameter | Group 1, | Group 2, |
|
|
|---|---|---|---|---|
| Overall infection rate | 44 (79 %) | 98 (49 %) |
|
|
| Wound infection rate | 9 (16 %) | 21 (11 %) | 0.2 (ns) | – |
| Cholangitis | 2 (4 %) | 3 (1.5 %) | 0.3 (ns) | – |
| Gastrointestinal infection | 1 (2 %) | 6 (3 %) | 0.5 (ns) | – |
| MRSA | 1 (2 %) | 0 | 0.2 (ns) | – |
| Clostridium | 1 (2 %) | 7 (3.5 %) | 0.5 (ns) | – |
| Sepsis | 1 (2 %) | 10 (5 %) | 0.3 (ns) | – |
| Oral candidiasis | 1 (2 %) | 2 (1 %) | 0.5 (ns) | – |
| Central venous catheter infection | 8 (14 %) | 32 (16 %) | 0.5 (ns) | – |
| Herpes simplex infection | 14 (25 %) | 47 (24 %) | 0.5 (ns) | – |
| CMV infection | 10 (18 %) | 36 (18 %) | 0.6 (ns) | – |
| Epstein-Barr virus | 0 | 1 (0.5 %) | 0.8 (ns) | – |
| CoNS | 29 (52 %) | 90 (45 %) | 0.2 (ns) | – |
| ESBL-producing Enterobacteriacae | 11 (20 %) | 22 (11 %) | 0.7 (ns) | – |
| Overall abdominal infection rate | 28 (50 %) | 45 (22.5 %) |
|
|
|
| 23 (41 %) | 39 (19.5 %) |
|
|
|
| 2 (4 %) | 1 (0.5 %) | 0.1 (ns) | – |
| Other | 3 (5 %) | 5 (3 %) | 0.2 (ns) | – |
Italic values indicate statistical significance of p value (p > 0.05)
Group 1 open-circuit drainage (Easy Flow Drain), Group 2 closed-circuit drainage (Robinson Drainage System)
Abdominal fungal infections following liver transplantation in subgroups with reoperation
| Parameter | Group 1, | Group 2, |
|
|---|---|---|---|
| Overall abdominal infection rate | 6 (19.5 %) | 19 (23 %) | 0.64 (ns) |
|
| 4 (13 %) | 15 (18 %) | 0.71 (ns) |
Group 1 open-circuit drainage (Easy Flow Drain), Group 2 closed-circuit drainage (Robinson Drainage System)